Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

4.
5.

rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.

Horwitz AH, Ammons WS, Bauer RJ, Dedrick R, Nadell R, Williams RE, Liu PS.

J Endotoxin Res. 2004;10(2):97-106.

PMID:
15120000
6.

Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats.

Jin H, Yang R, Marsters S, Ashkenazi A, Bunting S, Marra MN, Scott RW, Baker JB.

J Clin Invest. 1995 Apr;95(4):1947-52.

7.

A comparison of bactericidal/permeability-increasing protein variant versus recombinant endotoxin-neutralizing protein for the treatment of Escherichia coli sepsis in rats .

Stack AM, Saladino RA, Siber GR, Thompson C, Marra MN, Novitsky TJ, Fleisher GR.

Crit Care Med. 1997 Jan;25(1):101-5. Erratum in: Crit Care Med 1997 Mar;25(3):558.

PMID:
8989184
8.
10.

Protective effect of a recombinant amino-terminal fragment of bactericidal/permeability-increasing protein in experimental endotoxemia.

Kohn FR, Ammons WS, Horwitz A, Grinna L, Theofan G, Weickmann J, Kung AH.

J Infect Dis. 1993 Nov;168(5):1307-10.

PMID:
8228369
11.

Role of bactericidal permeability-increasing protein in the treatment of gram-negative pneumonia.

Kelly CJ, Cech AC, Argenteanu M, Gallagher H, Shou J, Minnard E, Daly JM.

Surgery. 1993 Aug;114(2):140-6.

PMID:
8342120
12.

Pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability increasing protein (rBPI21) after liver surgery in rats and humans.

Wiezer MJ, Langendoen SI, Meijer C, Bauer RJ, White ML, Carroll SF, Meyer S, Thijs LG, van Leeuwen PA.

Shock. 1998 Sep;10(3):161-6; discussion 167-8.

PMID:
9744643
13.
14.
15.

Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits.

Garcia C, Saladino R, Thompson C, Hammer B, Parsonnet J, Wainwright N, Novitsky T, Fleisher GR, Siber G.

Crit Care Med. 1994 Aug;22(8):1211-8.

PMID:
8045139
16.

Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebo-controlled study.

Fisher CJ Jr, Marra MN, Palardy JE, Marchbanks CR, Scott RW, Opal SM.

Crit Care Med. 1994 Apr;22(4):553-8.

PMID:
8143463
17.
18.

Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.

Giacometti A, Ghiselli R, Cirioni O, Mocchegiani F, D'Amato G, Orlando F, Sisti V, Kamysz W, Silvestri C, Naldoski P, Lukasiak J, Saba V, Scalise G.

J Antimicrob Chemother. 2004 Sep;54(3):654-60. Epub 2004 Aug 4.

PMID:
15294887
20.

[Protective effects of bactericidal/permeability-increasing protein on the vital organ function after endotoxic shock in rats].

Jiang J, Zhu P, Wang Z, Liu D, He Y, Xie G, Xu H.

Zhonghua Wai Ke Za Zhi. 1999 Feb;37(2):120-2. Chinese.

PMID:
11829800

Supplemental Content

Support Center